Crossmark Global Holdings’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-10,119
Closed -$100K 1435
2021
Q2
$100K Hold
10,119
﹤0.01% 1410
2021
Q1
$117K Sell
10,119
-713
-7% -$8.24K ﹤0.01% 1404
2020
Q4
$105K Sell
10,832
-2,415
-18% -$23.4K ﹤0.01% 1366
2020
Q3
$119K Sell
13,247
-400
-3% -$3.59K ﹤0.01% 1291
2020
Q2
$168K Hold
13,647
﹤0.01% 1266
2020
Q1
$123K Sell
13,647
-3,126
-19% -$28.2K ﹤0.01% 1146
2019
Q4
$164K Hold
16,773
﹤0.01% 1354
2019
Q3
$115K Sell
16,773
-201
-1% -$1.38K ﹤0.01% 1320
2019
Q2
$157K Sell
16,974
-712
-4% -$6.59K ﹤0.01% 1338
2019
Q1
$277K Hold
17,686
0.01% 1159
2018
Q4
$273K Hold
17,686
0.01% 1133
2018
Q3
$381K Hold
17,686
0.01% 1153
2018
Q2
$430K Sell
17,686
-503
-3% -$12.2K 0.01% 1047
2018
Q1
$311K Sell
18,189
-600
-3% -$10.3K 0.01% 1242
2017
Q4
$356K Sell
18,789
-3,550
-16% -$67.3K 0.01% 1254
2017
Q3
$393K Buy
+22,339
New +$393K 0.01% 1119
2016
Q3
$393K Buy
+22,339
New +$393K 0.01% 1119